News & Updates

Sarcoidosis patients on systemic corticosteroid at higher risk of death
Sarcoidosis patients on systemic corticosteroid at higher risk of death
02 Mar 2022

The risk of death is increased among patients with sarcoidosis compared with the general population, suggests a recent study, noting that mortality is even higher in those treated with systemic corticosteroids.

Sarcoidosis patients on systemic corticosteroid at higher risk of death
02 Mar 2022
Effective PrEP averts further cost for HIV treatment
Effective PrEP averts further cost for HIV treatment
02 Mar 2022

Effective treatment with pre-exposure prophylaxis (PrEP) for HIV puts a cap on the additional cost patients should be willing to pay for long-acting injectable cabotegravir (CAB-LA), reports a US study.

Effective PrEP averts further cost for HIV treatment
02 Mar 2022
Ligelizumab improves symptoms, QoL in patients with urticaria
Ligelizumab improves symptoms, QoL in patients with urticaria
02 Mar 2022 byAudrey Abella

In patients with chronic spontaneous urticaria (CSU) who remained symptomatic despite treatment, the monoclonal anti-immunoglobulin E antibody ligelizumab improved symptom control regardless of BHRA* status, as well as dermatology quality of life (QoL) regardless of angioedema status, findings from a phase IIb study have shown.

Ligelizumab improves symptoms, QoL in patients with urticaria
02 Mar 2022